. . "clinical trial"@en . . . "2022-12-04T00:00:00Z"^^ . "An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease"@en . . . "klinisch onderzoek"@nl . . . "16"^^ . . . . . . . . "NCT03759288" . "1140"^^ . . "\u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0435 \u0432\u0438\u043F\u0440\u043E\u0431\u0443\u0432\u0430\u043D\u043D\u044F"@uk . "80"^^ . "ensayu cl\u00EDnicu"@ast . . . "A 52-Week, Multicenter, Randomized, Double-blind, Double-dummy, Placebo and Active-Controlled, Operationally Seamless Phase 2b/3, Parallel-group Study to Assess the Efficacy and Safety of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease"@en . . . "An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease"@en . "An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease"@en . . . . . "2018-12-07T00:00:00Z"^^ .